• Rise of drug-resistant infections to cost millions of lives, trillions of dollars

    Drug-resistant infections could kill an extra ten million people across the world every year by 2050 if these infections are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy, and roughly equivalent to the world losing the output of the U.K. economy every year, for thirty-five years.

  • Climate change poses multiple threats to global food system

    Climate change is likely to have far-reaching impacts on food security throughout the world, especially for the poor and those living in tropical regions, according to a new international report. The report warns that warmer temperatures and altered precipitation patterns can threaten food production, disrupt transportation systems, and degrade food safety, among other impacts. As a result, international progress in the past few decades toward improving food security will be difficult to maintain.

  • view counter
  • U.S. bioterrorism detection program unreliable: GAO

    DHS’s BioWatch program aims to provide early indication of an aerosolized biological weapon attack. Until April 2014, DHS pursued a next-generation autonomous detection technology (Gen-3), which aimed to enable collection and analysis of air samples in less than six hours, unlike the current system (Gen-2), which requires manual intervention and can take up to thirty-six hours to detect the presence of biological pathogens. A GAO report found that DHS lacks reliable information about BioWatch Gen-2’s technical capabilities to detect a biological attack, and therefore lacks the basis for informed cost-benefit decisions about upgrades to the system.

  • Scientists create malaria-blocking mosquitoes

    Using a groundbreaking gene editing technique, scientists have created a strain of mosquitoes capable of rapidly introducing malaria-blocking genes into a mosquito population through its progeny, ultimately eliminating the insects’ ability to transmit the disease to humans. The technique holds the promise of eradicating a disease that sickens millions annually.

  • Study finds that Ebola vaccine is safe, stimulating strong immune responses

    A clinical trial of a new Ebola vaccine that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization (WHO) has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the United States. If the vaccine is ultimately found to be safe and effective, it could offer crucial protection for contacts (family members, neighbors, etc.) of patients with confirmed Ebola disease in future epidemics, thereby helping to interrupt transmission. Larger trials of the vaccine sponsored, by GSK Biologicals, have already begun.

  • How infectious diseases become epidemics

    Researchers are exploring how diseases spread across long distances in an effort to learn how better to control the next human, animal, or plant epidemic. The researchers will study data for vector-borne infectious diseases to model how these types of epidemics spread. Vector-borne diseases are spread by infectious microbes transmitted by ticks, mosquitos, or other insects or parasites.

  • view counter
  • Surface Enhanced Raman Scattering (SERS) technology for on-site detection

    Surface Enhanced Raman Scattering (SERS) technology currently is applied using chemical analysis of materials, such as scanning at airports to identify what materials may be inside of glass vials. Researchers want to expand SERS for use in biological applications that could employ antibodies for purposes such as identifying viruses, water toxins, or pathogens in food samples. The researchers work on developing a small hand-held device that allows users to take a sample, put it in a glass vial and insert into the instrument for rapid identification.

  • Novel statistical model maps lethal route of Ebola outbreak

    The traditional method to track disease spread is contract tracing, in which health workers interview patients and everyone they came into contact with. Contact tracing, however, is highly labor intensive. Using a novel statistical model, a research team mapped the spread of the 2014-15 Ebola outbreak in Sierra Leone, providing the most detailed picture to date on how and where the disease spread and identifying two critical opportunities to control the epidemic. The result matches with details known about the early phase of the Ebola outbreak, suggesting the real-time value of the new method to health authorities as they plan interventions to contain future outbreaks, and not just of Ebola.

  • Nanoparticle delivery maximizes drug defense against bioterrorism agent

    Scientists have developed a nanoparticle delivery system for the antibiotic moxifloxacin that vastly improves the drug’s effectiveness against pneumonic tularemia, a type of pneumonia caused by inhalation of the bacterium Francisella tularensis. The scientists show how the nanoparticle system targets the precise cells infected by the bacteria and maximizes the amount of drug delivered to those cells.

  • DoD awards $7.6 million to Pitt to develop therapies against biowarfare

    The U.S. Department of Defense (DOD) has awarded a $7.6 million grant to a collaborative group of scientists in the University of Pittsburgh Center for Vaccine Research (CVR) for work which could lead to countermeasures against bioterrorism attacks. The contract is the latest in a successful run of federal funding for this group of investigators within Pitt’s CVR, which the DOD acknowledges has performed well.

  • Killer bees send six to hospital in Arizona

    The Maricopa, Arizona fire department said six people were hospitalized on Saturday afternoon after a swarm of bees attacked residents in the Rancho El Dorado subdivision. The bees swooped down on residents of a two-block area in the subdivision about 5 p.m. Both kids and adults ran screaming for cover. Experts say the bees are a strain of the Africanized honeybee, also known as the killer bee, which is a crossbreed between the European honeybee and the African honeybee.

  • Oregon teen infected with bubonic plague

    Health authorities in Crook County, Oregon, confirmed that a teenage girl has contracted bubonic plague from a flea while on a hunting trip. The girl became sick five days after the trip started on 16 October; and was rushed to a hospital in Bend, Oregon on 24 October.

  • Centralized leadership, major reform needed to bolster U.S. biodefense

    A comprehensive report on U.S. biodefense efforts calls for major reforms to strengthen America’s ability to confront intentionally introduced, accidentally released, and naturally occurring biological threats. The report details U.S. vulnerability to bioterrorism and deadly outbreaks and emphasizes the need to transform the way the U.S. government is organized to confront these threats. Recommendations include centralizing leadership in the Office of the Vice President; establishing a White House Biodefense Coordination Council; strengthening state, local, territorial, and tribal capabilities; and promoting innovation through sustained biodefense prioritization and funding.

  • Syria’s civil war, Europe’s refugee crisis the result of spikes in food prices: Experts

    The disintegration of Syria and Europe’s refugee crisis are only the latest tragic consequences of two spikes in food prices in 2007-08 and 2010-11 that triggered waves of global unrest, including the Arab Spring. Researchers have traced these spikes and spiraling crises to their root causes: deregulated commodity markets, financial speculation, and a misguided U.S. corn-to-ethanol fuel policy which removes nearly five billion bushels of corn from markets each year.

  • $100 million NIAID contract to SRI International to develop radiation exposure treatment

    SRI International has been awarded a resource contract of up to $100 million over five years by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, for the development of products to mitigate or treat acute or delayed effects of radiation exposure.